Immune Deficiency Panel 2 Test in UAE | 310 AED | DHA Licensed

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Immune Deficiency Panel 2 Test is a comprehensive flow cytometry analysis that quantifies lymphocyte subsets (CD4+, CD8+, CD19+, CD16/56+) and cellular immune function, critical for diagnosing primary and secondary immunodeficiencies including AIDS. The methodology employs fluorescent flow cytometry under ISO 9001:2015 certified processes, ensuring high precision and reproducibility.

Feature	Our Test (Immune Deficiency Panel 2)	Closest Alternative (Basic Lymphocyte Count)
Precision	Quantitative subset analysis (CD4+, CD8+, CD19+, CD16/56+)	Total lymphocyte enumeration only
Method	Fluorescent Flow Cytometry ISO 9001:2015	Automated Hematology Analyzer
Speed	Same-day report (sample by 9 AM)	24-48 hours

Physician Insight & Safety Protocols

Mr. Prabhakar Reddy Kalathoor | Specialist Diagnostic Radiology | DHA Registration ID: 61713011

"Flow cytometry immunophenotyping must be interpreted alongside clinical history, physical examination, and immunoglobulins. This panel provides a snapshot of cellular immunity; serial monitoring is often required to differentiate primary from secondary deficiencies. Never adjust immunosuppressive therapy without consulting your specialist."

Advisory – Medication & Treatment Precautions

Do not discontinue prescribed medications, including corticosteroids or immunosuppressants, without direct consultation with your treating physician. This test evaluates immune function; results may be transiently altered by recent infections, vaccinations (within 72 hours), or high-dose steroid therapy. Disclose all medications and recent health events to the phlebotomist.

Exclusion Criteria & Emergency Red Flags

Exclusion: Do not schedule this test if you have an active febrile illness (temperature >38.5°C) or have received a live vaccine in the past 72 hours, as these may transiently alter lymphocyte counts.
Exclusion: Patients on high-dose corticosteroids or biologic immunosuppressants should reschedule testing in consultation with their physician.
ER Red Flags: Seek immediate emergency care if you experience sudden high fever (>39°C), severe shortness of breath, confusion, or signs of opportunistic infection (e.g., unexplained pneumonia, meningitis).

Patient FAQ & Clinical Guidance

1. What does the Immune Deficiency Panel 2 test measure?

The panel quantifies CD4+ T-helper cells, CD8+ cytotoxic T-cells, B-cells (CD19+), and NK cells (CD16/56+) to evaluate both cellular and humoral immunity. This helps diagnose conditions like HIV/AIDS, common variable immunodeficiency, and severe combined immunodeficiency.

2. How should I prepare for the blood draw?

No fasting is required; maintain normal hydration. Inform the phlebotomist of any recent infections, vaccinations, or medications (especially steroids or immunosuppressants). The sample must be kept at room temperature and not refrigerated to preserve lymphocyte viability.

3. Why must the blood sample be kept at room temperature and not refrigerated?

Refrigeration or freezing destroys lymphocyte viability and alters cell surface antigen expression, leading to inaccurate CD marker quantification. Our temperature-controlled transport ensures sample integrity for precise flow cytometry analysis.

UAE Regulatory & Data Privacy Adherence

This test is performed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. The facility is fully licensed by the Dubai Health Authority (DHA License No. 1143) and adheres to MOHAP home healthcare regulations. Home collection services are provided by licensed medical professionals using VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain protocols.

Clinical & Logistical Metadata

Test Name	Immune Deficiency Panel 2 Test
Price (AED)	310
Turnaround Time	Same day (sample by 9 AM)
Sample Type / Matrix	Peripheral whole blood (3 mL EDTA tube)
Methodology Used	Fluorescent Flow Cytometry (ISO 9001:2015)
ICD-10-CM Code	D84.9 (Immunodeficiency, unspecified)
LOINC Code	48715-0 (Lymphocyte Count and Subset Panel)
DHA Facility License & Laboratory Address	License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE